Latest reported quarter: Q2, ended Jun 2026
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Revenue as Reported | $214.20M | $212.66M | $847.33M | $215.32M | $212.46M |
| Total Operating Revenue | $214.20M | $227.26M | $774.43M | $142.42M | $212.46M |
| Total Premiums Earned | $201.12M | $199.69M | $794.16M | $202.68M | $195.13M |
| -Net Premiums Written | $238.41M | $192.88M | $802.16M | $179.94M | $166.33M |
| -Increase Decrease in Net Unearned Premium Reserves | -$37.29M | $6.82M | -$8.01M | $22.74M | $28.80M |
| Fee Revenue and Other Income | $2.51M | $17.68M | -$59.60M | -$70.09M | $4.90M |
| -Other Income Expense | $2.51M | $3.08M | $13.30M | $2.81M | $4.90M |
| Net Investment Income | $6.79M | $6.47M | $37.16M | $9.86M | $9.69M |
| Net Realized Gain/Loss on Investments | $3.77M | $3.41M | $2.71M | -$33,000.00 | $2.75M |
| Total Expenses | $132.04M | $178.22M | $515.17M | $54.47M | $144.14M |
| Loss Adjustment Expense | $61.06M | $91.60M | $313.25M | $63.45M | $74.77M |
| Policy Acquisition Expense | $45.51M | $56.34M | $119.16M | -$14.98M | $45.18M |
| Selling and Admin Expenses | $23.78M | $28.51M | $74.87M | $4.27M | $22.35M |
| -General & Admin Expense | $23.78M | $28.51M | $74.87M | $4.27M | $22.35M |
| Net Non-Operating Interest Income (Expense) | -$1.69M | -$1.78M | -$7.89M | -$1.73M | -$1.85M |
| -Interest Expense Non-Operating | $1.69M | $1.78M | $7.89M | $1.73M | $1.85M |
| Pretax Profit | $82.16M | $49.04M | $259.26M | $87.95M | $68.32M |
| Tax | $20.45M | $12.56M | $63.67M | $21.27M | $17.90M |
| Net Profit | $61.71M | $36.48M | $195.59M | $66.68M | $50.42M |
| Profit from Continuing Operations | $61.71M | $36.48M | $195.59M | $66.68M | $50.42M |
| Net Income to Parent Company | $61.71M | $36.48M | $195.59M | $66.68M | $50.42M |
| Net Income to Common Stockholders | $61.71M | $36.48M | $195.59M | $66.68M | $50.42M |
| Basic EPS | $2.06 | $1.19 | $6.33 | $2.16 | $1.63 |
| Diluted EPS | $2.05 | $1.19 | $6.32 | $2.15 | $1.63 |
| Dividend Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| -Fees and Commissions | – | $14.60M | -$72.90M | – | – |
| Special Income (Charges) | – | – | $0.00 | – | – |
| -Less:Impairment of Capital Assets | – | – | $0.00 | – | – |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Total Assets | $2.45B | $2.02B | $2.20B | $2.20B | $2.37B |
| Cash and Cash Equivalents | $587.60M | $517.07M | $559.27M | $559.27M | $560.44M |
| Restricted Cash and Cash Equivalents | $13.78M | $16.22M | $13.31M | $13.31M | $13.29M |
| Total Investments | $803.99M | $753.72M | $715.59M | $715.59M | $703.18M |
| -Short Term Investments | $127.90M | $107.99M | $99.41M | $99.41M | $105.94M |
| -Equity Investments | $674.83M | $644.46M | $614.89M | $614.89M | $595.95M |
| -Other Invested Assets | $1.26M | $1.26M | $1.29M | $1.29M | $1.29M |
| Receivables | $399.21M | $355.17M | $426.05M | $426.05M | $473.42M |
| -Accounts Receivable | $399.21M | $355.17M | $413.92M | $413.92M | $467.01M |
| Accrued Investment Income | $7.51M | $6.27M | $6.56M | $6.56M | $5.47M |
| Net PPE | $45.18M | $46.75M | $45.73M | $45.73M | $46.01M |
| Goodwill and Other Intangible Assets | $27.15M | $28.64M | $30.19M | $30.19M | $31.73M |
| -Other Intangible Assets | $27.15M | $28.64M | $30.19M | $30.19M | $31.73M |
| Prepaid Assets | $460.69M | $194.61M | $325.77M | $325.77M | $426.12M |
| Deferred Policy Acquisition Costs | $68.92M | $64.37M | $64.54M | $64.54M | $66.79M |
| Other Assets | $32.42M | $32.58M | $2.96M | $2.96M | $33.42M |
| Total Liabilities | $1.88B | $1.50B | $1.69B | $1.69B | $1.93B |
| Policy Holders Liabilities | $1.25B | $1.28B | $1.31B | $1.31B | $1.41B |
| Short-Term Debt and Capital Lease Obligation | $72.19M | $73.13M | $74.06M | $74.06M | $75.00M |
| -Current Debt | $72.19M | $73.13M | $74.06M | $74.06M | $75.00M |
| Payables | $539.17M | $120.65M | $275.29M | $275.29M | $411.39M |
| -Accounts Payable | $517.01M | $90.78M | $251.65M | $251.65M | $394.58M |
| -Total Tax Payable | $5.66M | $15.50M | $4.28M | $4.28M | $0.00 |
| -Other Payable | $16.51M | $14.37M | $19.36M | $19.36M | $16.81M |
| Current Accrued Expenses | $33,000.00 | $24,000.00 | $26,000.00 | $26,000.00 | $40,000.00 |
| Long Term Debt and Capital Lease Obligation | $19.65M | $25.92M | $25.75M | $25.75M | $26.66M |
| -Long Term Debt | -$901,000.00 | $4.49M | $4.37M | $4.37M | $4.25M |
| -Long Term Capital Lease Obligation | $20.55M | $21.44M | $21.39M | $21.39M | $22.41M |
| Employee Benefits | $6.62M | $4.90M | $8.84M | $8.84M | $7.73M |
| Other Liabilities | $33,000.00 | $63,000.00 | $36,000.00 | $36,000.00 | $36,000.00 |
| Total Equity | $567.73M | $520.37M | $505.25M | $505.25M | $437.25M |
| Stockholders' Equity | $567.73M | $520.37M | $505.25M | $505.25M | $437.25M |
| Capital Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| -Common Stock | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 | $3,000.00 |
| Additional Paid-In Capital | $359.50M | $357.81M | $365.74M | $365.74M | $366.80M |
| Retained Earnings | $381.44M | $319.73M | $283.25M | $283.25M | $216.58M |
| Less: Treasury Stock | $157.77M | $143.19M | $133.18M | $133.18M | $133.18M |
| Gains/Losses Not Affecting Retained Earnings | -$15.45M | -$13.99M | -$10.56M | -$10.56M | -$12.94M |
| -Other Receivables | – | – | $12.13M | $12.13M | – |
| -Taxes Receivable | – | – | – | – | $6.41M |
| Line item | 2026 Q2 | 2026 Q1 | 2025 ANNUAL | 2025 Q4 | 2025 Q3 |
|---|---|---|---|---|---|
| Operating Cash Flow | $141.69M | $24.86M | $182.24M | $13.81M | $124.30M |
| Net cash flow from continuing operations | $141.69M | $24.86M | $182.24M | $13.81M | $124.30M |
| Net Income from Continuing Operations | $61.71M | $36.48M | $195.59M | $66.68M | $50.42M |
| Deferred Tax | $38,000.00 | $1.34M | $2.38M | $950,000.00 | $2.36M |
| Other Non-Cash Items | -$156,000.00 | -$61,000.00 | -$1.84M | $97,000.00 | -$2.14M |
| Change in Working Capital | $75.63M | -$17.01M | -$28.85M | -$58.44M | $71.92M |
| -Change in Receivables | -$43.92M | $58.83M | $428.05M | $59.40M | $169.40M |
| -Change in Prepaid Assets | -$266.09M | $112.43M | $2.76M | $119.08M | $104.17M |
| -Change in Loss and Loss Adjustment Expense Reserves | -$62.05M | -$35.43M | -$463.21M | -$70.11M | -$63.60M |
| -Change in Deferred Acquisition Costs | -$4.55M | $177,000.00 | -$1.34M | $2.25M | $4.15M |
| -Change in Accrued Investment Income | -$1.24M | $284,000.00 | -$964,000.00 | -$1.09M | $83,000.00 |
| -Change in Payables and Accrued Expense | $419.41M | -$152.03M | $9.22M | -$140.31M | -$122.18M |
| -Change in Unearned Premiums | $33.13M | $4.80M | $9.19M | -$32.64M | -$21.11M |
| -Change in Other Current Assets | $1.01M | $414,000.00 | -$7.70M | $548,000.00 | $4.44M |
| -Change in Other Current Liabilities | -$75,000.00 | -$6.48M | -$4.86M | $4.43M | -$3.43M |
| Net cash flow from investing | -$52.58M | -$44.30M | -$32.67M | -$11.57M | -$24.36M |
| Net Cash Flow from Continuing Investing Activities | -$52.58M | -$44.30M | -$32.67M | -$11.57M | -$24.36M |
| Net PPE Purchase and Sale | -$657,000.00 | -$1.82M | -$4.89M | -$2.59M | $1.33M |
| Net Investment Purchase and Sale | -$52.16M | -$42.49M | -$27.76M | -$8.98M | -$25.67M |
| Financing Cash Flow | -$21.02M | -$19.85M | -$40.63M | -$3.38M | -$13.15M |
| Net Cash Flow from Continuing Financing Activities | -$21.02M | -$19.85M | -$40.63M | -$3.38M | -$13.15M |
| Net Issuance Payments of Debt | -$938,000.00 | -$938,000.00 | -$36.05M | -$20.29M | -$10.87M |
| Net Common Stock Issuance | -$14.58M | -$10.01M | -$2.28M | $0.00 | -$2.28M |
| Net Other Financing Charges | -$5.50M | -$8.91M | -$2.30M | $16.90M | $0.00 |
| Ending Cash Balance | $601.38M | $533.29M | $572.58M | $572.58M | $573.73M |
| Net Change in Cash | $68.09M | -$39.29M | $108.94M | -$1.14M | $86.79M |
| Beginning Cash Balance | $533.29M | $572.58M | $463.65M | $573.73M | $486.93M |
| Free Cash Flow | $141.03M | $23.05M | $174.16M | $10.95M | $122.72M |
| Net Other Investing Changes | – | $17,000.00 | – | – | – |
| Gain/Loss from Continuing Operations | – | – | -$2.71M | $33,000.00 | -$2.74M |
No comments yet — be the first to weigh in on HRTG.